Key Highlights

  • MicroSalt plc (LSE:SALT) was among the strongest movers in the latest market snapshot, gaining 14.29% on 28 September 2026.
  • Investor attention is focused heavily on the company’s 29 September interim results covering the six months ended 30 June 2026.
  • The company recently secured a significantly oversubscribed subscription of approximately £1.3 million, while a separate retail offer could raise another £100,000.
  • MicroSalt has also converted approximately US$2.4 million of convertible Loan notes into equity, reducing Debt obligations and strengthening the balance sheet.
  • Investors are watching the potential commercial impact of a third product line from a major global snack and beverage customer, expected during Q4 2026, although timing remains an important variable.
  • The company remains in its commercialisation phase and continues to consume cash, making Revenue growth, funding and working-capital management key areas to watch.

Why Is MicroSalt (LSE:SALT) in Focus Today?

MicroSalt (LSE:SALT) has attracted renewed market attention after climbing 14.29% on 28 September 2026. The move comes immediately ahead of a potentially important period for the company, with interim financial results due on 29 September and the current retail fundraising process approaching its deadline.

The timing is significant because investors are likely assessing whether MicroSalt can convert its expanding commercial pipeline into materially higher revenue while simultaneously managing its funding requirements.

The company specialises in full-flavour salt products designed to deliver approximately 50% less sodium than conventional salt. Its technology is aimed at food manufacturers and consumers seeking sodium reduction without sacrificing taste.

That positioning gives LSE:SALT exposure to the broader food-health trend around sodium reduction, reformulation and healthier packaged-food products.

What Triggered the Latest Interest in LSE:SALT?

One of the clearest recent catalysts has been MicroSalt’s fundraising.

The company announced that its main subscription was significantly oversubscribed, raising approximately £1.3 million before expenses through 9,213,858 shares priced at 14 pence each. A director subscription was expected to provide another approximately £140,000, while a retail offer could raise up to £100,000 if fully subscribed.

For investors, the fundraising has two sides.

On one hand, additional Capital can provide MicroSalt with the Working Capital required to support inventory, customer orders and commercial expansion.

On the other hand, the issuance of new shares and accompanying warrants increases the potential share count, meaning investors will continue to monitor dilution and the relationship between new capital and future revenue growth.

The retail offer is scheduled to close on 29 September 2026, with results expected on 30 September and the new shares expected to begin trading on 5 October, subject to the relevant conditions.

Why Are Tomorrow’s Interim Results Important?

MicroSalt is scheduled to publish its interim results for the six months ended 30 June 2026 on 29 September 2026.

This creates an immediate catalyst for LSE:SALT.

Investors will be looking for evidence of:

  • Revenue growth compared with the previous year
  • Progress in bulk salt sales
  • Customer order momentum
  • Gross-margin development
  • Cash consumption
  • Inventory requirements
  • Commercialisation progress
  • Progress towards monthly cash-flow positivity
  • Updated expectations for 2026 and FY27

The company previously indicated that first-half 2026 sales reached approximately US$1.4 million, around US$0.6 million higher than the comparable period in 2025. Bulk sales reportedly reached approximately US$1.3 million during the first half.

However, MicroSalt was still operating at a loss, with unaudited first-half EBITDA expected to be approximately US$1.2 million negative.

That makes the upcoming results particularly important because investors need to assess whether rising sales are progressing quickly enough to support the company's stated path toward cash-flow-positive monthly performance.

Could Customer Expansion Become the Bigger Catalyst for LSE:SALT?

Potential customer expansion could become one of the most important drivers for MicroSalt.

The company has said that a third product line from a major global snack and beverage customer is expected during Q4 2026. Management expects the rollout to materially increase monthly revenue and potentially support a move towards cash-flow-positive monthly performance.

MicroSalt has also indicated that recipe reformulations and production trials for the customer's major product rollout have been completed.

However, the timing of the associated inventory build has not been fully fixed, with Q4 2026 or Q1 2027 previously identified as possibilities.

That means investors may focus less on headline customer announcements and more on actual purchase orders, shipment volumes, production schedules and recurring revenue.

What Does the Balance Sheet Mean for MicroSalt Stock?

Another major development has been the conversion of approximately US$2.4 million of convertible loan notes into equity.

The conversion removed a substantial portion of the associated repayment Liability and was described as strengthening MicroSalt’s balance sheet.

At the same time, the company remained a monthly net user of cash, with gross cash reported at approximately US$260,000 as of 31 August 2026.

This explains why the fundraising is strategically important.

The additional capital is intended for general working capital and inventory requirements as MicroSalt prepares for anticipated additional orders.

What Should Investors Watch Next for LSE:SALT?

The immediate focus is likely to remain on the sequence of corporate milestones:

  • 29 September: Interim results for the six months ended 30 June 2026.
  • 29 September: Deadline for commitments under the retail offer.
  • 30 September: Expected announcement of retail-offer results.
  • 2 October: General meeting relating to the fundraising.
  • 5 October: Expected admission and commencement of dealings in the fundraising shares, subject to conditions.

Beyond these dates, investors will likely concentrate on customer volumes, new product launches, cash usage and whether MicroSalt can convert its commercial pipeline into sustained revenue growth.

What Could Explain the 14.29% Move on 28 September 2026?

The 14.29% gain appears to coincide with several near-term catalysts rather than a single newly announced operating event.

The strongest identifiable factors are the approaching interim results, the significantly oversubscribed fundraising, the retail offer deadline and expectations surrounding the company's next major customer rollout.

The share-price reaction therefore appears consistent with increased attention around MicroSalt’s financing position and commercial outlook, although the exact contribution of each Factor cannot be isolated from the available information.

The key question now is whether the upcoming financial results and subsequent commercial milestones can provide further evidence of accelerating revenue and improving cash generation.

MicroSalt (LSE:SALT) Outlook

MicroSalt enters this week with several important developments converging at the same time. The 14.29% share-price rise places additional attention on the company just before its interim results.

The Investment narrative is increasingly centred on three areas: commercial scale-up, funding and the transition towards cash-flow positivity.

The Business has demonstrated sales growth and customer development, while the latest fundraising provides additional working capital. However, continued cash consumption and the need to fund inventory remain important considerations.

For LSE:SALT, the next stage will depend increasingly on execution: converting customer programmes into recurring orders, expanding volumes, managing working capital and demonstrating that revenue growth can eventually outpace cash requirements.